Overcoming ROS Resistance of Photodynamic Therapy with Self‐Assembled Nano‐Prodrugs for Efficient Triple‐Negative Breast Cancer
Bowen Li,Jianwu Tian,Xin Xie,Fu Zhang,Chongzhi Wu,Yi Shan,Guobin Qi,Wentao Song,Yuan Ping,Bin Liu
DOI: https://doi.org/10.1002/adfm.202309524
IF: 19
2023-10-26
Advanced Functional Materials
Abstract:A small molecular self‐assembly nano‐prodrug (CM‐SSZ‐SS‐PS NPs), composed of an activatable photosensitizer and ROS resistance inhibitor, is developed for the efficient treatment of triple‐negative breast cancer. The SSZ‐SS‐PS NPs are not active in normal tissues but can be activated to release both PS and SSZ to offer efficient PDT with inhibited ROS resistance in TNBC tumor. Triple‐negative breast cancer (TNBC) is endowed with a highly aggressive nature that results in distant metastases and high recurrence rates, yet limited success is realized in traditional chemotherapy. Activatable photosensitizers (PSs) may provide an effective and non‐invasive strategy to induce TNBC cell death in a precise way by offering stimuli‐responsive reactive oxygen species (ROS). However, the toxicity of ROS is often mitigated and even devitalized by the instinctive behavior of ROS resistance in TNBC cells. To address this issue, herein a small molecular self‐assembly nano‐prodrug is presented to co‐deliver an activatable PS and ROS resistance inhibitor. In TNBC cells, the overexpressed glutathione can disassemble the nano‐prodrug, thereby releasing ROS resistance inhibitor and activating the PS for photodynamic therapy and fluorescence imaging. A hybrid membrane coating‐assisted nanoparticle formation strategy is further demonstrated for efficient inhibition of tumor growth and distant metastases on both subcutaneous and orthotopic TNBC mice models.
materials science, multidisciplinary,chemistry, physical,physics, applied, condensed matter,nanoscience & nanotechnology